Chemours
418 hedge funds and large institutions have $1.96B invested in Chemours in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 116 increasing their positions, 153 reducing their positions, and 113 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
37% less capital invested
Capital invested by funds: $3.12B → $1.96B (-$1.16B)
59% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 113
71% less call options, than puts
Call options by funds: $25.9M | Put options by funds: $90.6M
Holders
418
Holding in Top 10
5
Calls
$25.9M
Puts
$90.6M
Top Buyers
| 1 | +$74.7M | |
| 2 | +$69.6M | |
| 3 | +$41.3M | |
| 4 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
+$28M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.1M |
Top Sellers
| 1 | -$105M | |
| 2 | -$30.5M | |
| 3 | -$26M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$25.4M |
| 5 |
Goldman Sachs
New York
|
-$19.5M |